Kevin McKernan is a renowned leader in DNA sequencing technology. He led a research team part of the original Human Genome Project and is the founder and Chief Science Officer of Medicinal Genomics, a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis.
Nick and Kevin discussed the Cannabis genome, the genome of Psilocybe cubensis (magic mushrooms); Polymerase Chain Reaction (PCR) technology, how it works, and how it’s used for COVID-19 testing; cannabinoids such as cannabidiol (CBD) and recent research indicating their potential anti-SARS-CoV-2 effects; blockchain technology for genomics data; and mRNA vaccines and SARS-CoV-2.
USEFUL LINKS
Sign up for the weekly Mind & Matter newsletter
[https://mindandmatter.substack.com/?sort=top]
Download the podcast & follow Nick at his website
[https://www.nickjikomes.com]
Follow Nick’s work through Linktree:
[https://linktr.ee/trikomes]
Athletic Greens, comprehensive daily nutrition (Free 1-year supply Vitamin D w/ purchase)
[https://www.athleticgreens.com/mindandmatter]
Organize your digital highlights & notes w/ Readwise (2 months free w/ sub)
[https://readwise.io/nickjikomes/]
Learn more about our podcast sponsor, Dosist
[https://dosist.com]
0:00:00 Episode Intro
0:03:25 Kevin McKernan Intro
0:07:33 Cannabis Genome
0:23:30 Cannabis Genome Data
0:50:00 Polymerase Chain Reaction (PCR)
0:56:32 COVID Testing
1:03:17 CBD as an antiviral drug
1:10:38 SARS-CoV-2 mRNA vs. mRNA vaccines
1:21:09 Psilocybe mushroom genome
1:28:24 Blockchain Tech for Genomics Data
1:34:04 Upcoming Genomics Research
source
